Inhaled heparin significantly lowers the risk of death and ventilation in COVID-19 patients while also showing potential against other respiratory infections. With its unique triple-action benefits, ...

Heparin, a widely available drug traditionally used to treat blood clots, lowers risk of death and ventilation in patients with COVID-19. The corresponding study was published in eClinical Medicine.

Nonsteroidal anti-inflammatory drugs, commonly used pain relievers, may increase the risk of a heart attack when used during an acute respiratory illness, according to a study published in the Journal ...

Respiratory infectious diseases, such as viral pneumonia, pose a serious threat to global public health. These diseases spread rapidly and widely, potentially causing severe complications such as ...